Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Predicting Physiotherapy Management of Musculoskeletal Abnormalities by 2030—A Phase-Specific Evidence-Based Protocol Integrating DNA-Level Prognostic Insights
0
Zitationen
1
Autoren
2025
Jahr
Abstract
The forecasting model underpinning future adoption of phase-specific, DNA-informed physiotherapy protocols employs a hybrid methodological framework, integrating population-level epidemiological data, genomic biobank insights, and contemporary clinical adoption trends. Key assumptions include: - The routine clinical utility of DNA-based prognostic profiling for musculoskeletal disorders by 2030, facilitated by declining costs and expanded biorepository access. - Accelerated adoption of digital health and AI-powered rehabilitation technologies, following a sigmoidal (logistic) growth curve, sensitive to sociodemographic and policy variables. - Stratified patient management anchored both in genomic risk and longitudinal function, enabling precision technology deployment and tailored rehabilitation intensity.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.245 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.102 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.468 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.429 Zit.